Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy

Leukemia. 2014 Aug;28(8):1759-62. doi: 10.1038/leu.2014.116. Epub 2014 Mar 28.

¹ Department of Internal Medicine III, University of Ulm, Ulm, Germany.
² 1] Department of Internal Medicine III, University of Ulm, Ulm, Germany [2] Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
⁴ Department of Pathology, University of Ulm, Ulm, Germany.
⁵ 1] Department of Internal Medicine III, University of Ulm, Ulm, Germany [2] Department of Internal Medicine, Diakonie Hospital Stuttgart, Stuttgart, Germany.

No abstract available

Publication types